Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepiness

Pharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treating excessive daytime sleepiness in patients. The US health regulator approved strengths of 4.45 mg and 17.8 mg. Lupin's Pitolisant tablets are bioequivalent to Wakix, a prescription medicine. This approval marks a significant step for the company in the US market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EmgD0VJ
via IFTTT

Read More

Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA

Aurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufacturing plant. This classification allows applications for inhalers and other products to proceed. The inspection covered inhaler, dermatology, and transdermal product manufacturing operations. The company's regulatory filing confirmed the inspection closure and VAI status.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0Vnv42K
via IFTTT

Read More

India plans national sports medicine framework ahead of 2036 Olympics

India plans a national sports medicine framework for preventive athlete care. This initiative aims to standardize injury protocols and link medical institutions. The government considers a phased rollout by 2028 for this new system. This framework will improve athlete availability and long-term career sustainability. The proposal supports India's potential 2036 Olympic Games bid.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7stunQp
via IFTTT

Read More

In private healthcare's rise, price points are a big pain

In a recent proposal, a parliamentary committee has recommended that hospital room charges not exceed the rates of three-star hotels. The substantial growth of private healthcare as an industry has attracted considerable private equity investment, resulting in valuation spikes and shifts in ownership among hospital chains. However, this raises important questions about the accessibility of healthcare for the average person.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UQe6Rc9
via IFTTT

Read More

AI could cut doctors' paperwork burden as global health worker shortage looms: Report

Artificial intelligence can ease doctor workloads by handling repetitive administrative tasks. This technology helps address a growing global healthcare worker shortage. AI tools can draft clinical documentation, freeing up valuable physician time. Patients can also benefit as AI helps direct them to appropriate care. Ultimately, AI aims to optimize existing healthcare staff for future demands.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ci0UH8Y
via IFTTT

Read More

Thermo Fisher finds India the perfect lab; lab equipment maker steps up investments as drug companies focus on innovation

Thermo Fisher Scientific is amplifying its investment footprint in India, driven by the strong anticipated growth in the biosimilars and innovative medicines sectors. With projections indicating a substantial rise in India's biosimilars exports by 2030, local pharmaceutical companies are pivoting towards advanced biologics and research initiatives. To foster scientific talent, Thermo Fisher has also established a bioprocess center in Hyderabad for comprehensive training.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TPJej1A
via IFTTT

Read More

Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDA

Aurobindo Pharma announced its subsidiary Eugia Pharma received a USFDA warning letter. This follows an inspection of their Telangana formulation manufacturing facility. The inspection concluded with four observations and an official action indicated status. The company stated existing US market supplies remain unaffected by this development. Aurobindo Pharma continues its commitment to ongoing compliance with the US FDA.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ftbaj2p
via IFTTT

Read More